Naturally-Derived 5 mg Psilocybin Capsules Mark the Company’s Second Drug in Market Under Australia’s Authorised Prescriber Scheme Vancouver, British Columbia–(Newsfile Corp. – February 19, 2026) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a Health Canada-licensed manufacturer of pharmaceutical-grade psychedelic drug products, today announced …
Read More »
Breaking News
- PURE EV Powers Up Guwahati. The Electric Revolution Has a New Address
- Green Arrow Resources Inc. Announces Extension to Private Placement and Update on Consolidation of Common Shares
- Builders Capital Mortgage Corp. Announces Class A Non-Voting Share Distribution
- AbraSilver’s Definitive Feasibility Study Positions Diablillos Among the Premier Undeveloped Silver-Gold Projects Globally with CAD$4.2B After-Tax NPV5% & 42% IRR
- Goldmoney Inc. Reports Fiscal Year 2026 Annual Results and Publishes Annual Letter to Shareholders
- Twenty Mile Metals Inc. Announces Listing on the TSX Venture Exchange
- Custom Health Holdings Inc. to Commence Trading on the Toronto Stock Exchange
- Bullion Announces Results of Annual General Meeting
- Crombie REIT Announces Offering of $300 Million Series N Unsecured Notes
- Clear Blue Technologies Announces FY2025 and Q1 2026 Results
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar